Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.
Deborah Elstein,
Nadia Belmatoug,
Patrick Deegan,
Özlem Göker-Alpan,
Derralynn A Hughes,
Ida Vanessa D Schwartz,
Neal Weinreb,
Nicola Bonner,
Charlotte Panter,
Donna Fountain,
Andrew Lenny,
Louise Longworth,
Rachael Miller,
Koonal Shah,
Jörn Schenk,
Rohini Sen,
Ari Zimran
OAI: oai:www.repository.cam.ac.uk:1810/332533 • DOI: 10.17863/CAM.79983